Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
101 studies found for:    Open Studies | "Conjunctivitis"
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Unknown  A Trial of Topical Dexamethasone Versus Artificial Tears for Treatment of Viral Conjunctivitis
Condition: Viral Conjunctivitis
Interventions: Drug: dexamethasone 0.1%/povidone-iodine 0.4%;   Drug: Artificial Tears
2 Recruiting Hydrocortisone Ophthalmic Ointment 0.5% for Treatment of Allergic Conjunctivitis
Condition: Allergic Conjunctivitis
Interventions: Drug: hydrocortisone ophthalmic ointment 0.5%;   Drug: placebo
3 Unknown  Evaluate the Use of Ganciclovir Gel 0.3% for the Treatment of Conjunctivitis Caused by Adenovirus
Conditions: Conjunctivitis;   Adenovirus.
Interventions: Drug: Ophthalmic gel (placebo);   Drug: Ganciclovir
4 Recruiting Efficacy/Safety of Human Plasminogen Eye Drop in Ligneous Conjunctivitis Patients
Condition: Ligneous Conjunctivitis
Intervention: Biological: Human Plasminogen
5 Unknown  Efficacy Maxinom® And Maxitrol® in Reducing The Signs And Symptoms Of Acute Bacterial Conjunctivitis
Conditions: Bacterial Conjunctivitis;   Acute
Interventions: Drug: MAXINOM®;   Drug: Maxitrol®
6 Unknown  Effectiveness Comparison Between the Drugs TOBRACORT® and TOBRADEX® in Reducing the Signs and Symptoms of Acute Bacterial Conjunctivitis
Condition: Acute Bacterial Conjunctivitis
Interventions: Drug: Tobracort;   Drug: Tobradex
7 Recruiting Efficacy and Safety of Auriclosene (NVC-422) in the Treatment of Bacterial Conjunctivitis
Condition: Bacterial Conjunctivitis
Interventions: Drug: Auriclosene Ophthalmic Solution;   Drug: Vehicle Ophthalmic Solution
8 Unknown  Moxifloxacin vs. Polytrim for Conjunctivitis
Condition: Conjunctivitis
Interventions: Drug: moxifloxacin;   Drug: polytrim
9 Recruiting Compare Dose Regimens of AllerT, in Adults With Allergic Rhino-Conjunctivitis to Birch Pollen Studied in Environmental Exposure Chamber
Condition: Allergic Rhino-Conjunctivitis
Intervention: Drug: AllerT
10 Recruiting ADenoVirus Initiative Study in Epidemiology in France
Condition: Viral Conjunctivitis
Intervention:
11 Recruiting ADenoVirus Initiative Study in Epidemiology in Spain
Condition: Viral Conjunctivitis
Intervention:
12 Recruiting ADenoVirus Initiative Study in Epidemiology in Germany
Condition: Viral Conjunctivitis
Intervention:
13 Not yet recruiting ADenoVirus Initiative Study in Epidemiology in UK
Condition: Viral Conjunctivitis
Intervention:
14 Recruiting AGN-229666 Ophthalmic Solution in Japanese Patients With Allergic Conjunctivitis
Condition: Conjunctivitis, Allergic
Interventions: Drug: AGN-229666;   Drug: Vehicle to AGN-229666;   Drug: Olopatadine
15 Recruiting Safety and Tolerability of XmAb®7195 in Adult Healthy Volunteers and Adult Subjects With a History of Allergic Rhinitis and/or Allergic Conjunctivitis and/or Atopic Dermatitis
Conditions: Allergic Rhinitis;   Allergic Conjunctivitis;   Atopic Dermatitis
Interventions: Biological: XmAb7195;   Biological: Placebo
16 Unknown  A Patient Reported Ocular Comfort Assessment Comparing Bepreve to Lastacaft
Condition: Allergic Conjunctivitis
Intervention:
17 Recruiting A Multi-Center Study Evaluating the Safety of AC-170 0.24%
Condition: Atopc Disease (Including Allergic Conjunctivitis)
Interventions: Drug: Drug: AC-170 0.24%;   Drug: AC-170 0%
18 Unknown  Antibiotic Steroid Combination Compared With Individual Administration in the in the Treatment of Ocular Inflammation and Infection
Conditions: Ocular Inflammation;   Infection Associated Blepharitis;   Keratitis;   Conjunctivitis, Bacterial
Interventions: Drug: azithromycin 1.5%/Loteprednol 0,5% + placebo;   Drug: azithromycin 1.5% + Loteprednol 0,5% (separately)
19 Recruiting A Placebo Controlled Comparison of Topical Zirgan Versus Genteal Gel for the Treatment of Adenovirus Conjunctivitis
Conditions: Keratoconjunctivitis Due to Adenovirus;   Viral Shedding
Interventions: Drug: Zirgan;   Drug: genteal gel
20 Not yet recruiting Observational Study of Oralair® in Children 5-9 Years With Grass-pollen-induced Allergic Rhinitis With/Without Conjunctivitis
Condition: Allergy
Intervention: Drug: Oralair

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years